GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (FRA:HPX) » Definitions » EBIT per Share

Hisamitsu Pharmaceutical Co (FRA:HPX) EBIT per Share : €1.68 (TTM As of Aug. 2024)


View and export this data going back to . Start your Free Trial

What is Hisamitsu Pharmaceutical Co EBIT per Share?

Hisamitsu Pharmaceutical Co's EBIT per Share for the three months ended in Aug. 2024 was €0.52. Its EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 was €1.68.

During the past 12 months, the average EBIT per Share Growth Rate of Hisamitsu Pharmaceutical Co was -4.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 9.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was -11.50% per year. During the past 10 years, the average EBIT per Share Growth Rate was -7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's EBIT per Share or its related term are showing as below:

FRA:HPX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -26   Med: -3.3   Max: 13.2
Current: 9.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Hisamitsu Pharmaceutical Co was 13.20% per year. The lowest was -26.00% per year. And the median was -3.30% per year.

FRA:HPX's 3-Year EBIT Growth Rate is ranked better than
53.47% of 836 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs FRA:HPX: 9.40

Hisamitsu Pharmaceutical Co's EBIT for the three months ended in Aug. 2024 was €38.4 Mil.


Hisamitsu Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co EBIT per Share Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.65 1.17 1.22 1.43 1.55

Hisamitsu Pharmaceutical Co Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.41 0.21 0.55 0.52

Hisamitsu Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Hisamitsu Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Feb. 2024 is calculated as

EBIT per Share(A: Feb. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=118.986/76.998
=1.55

Hisamitsu Pharmaceutical Co's EBIT per Share for the quarter that ended in Aug. 2024 is calculated as

EBIT per Share(Q: Aug. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=38.434/73.455
=0.52

EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co  (FRA:HPX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Hisamitsu Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.